Based on SEC filing data. A biotech company founded in 2015 and based in Lexington, MA, raised $100.0M through a convertible note offering. The company is structured as an LLC and operates at the growth stage.
Get notified the moment Antigenics LLC/DE files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.